<DOC>
	<DOC>NCT00548080</DOC>
	<brief_summary>Registration study</brief_summary>
	<brief_title>Evaluate the Safety and Efficacy of Caspofungin Acetate as Empirical Therapy in Chinese Adults With Persistent Fever and Neutropenia (0991-055)</brief_title>
	<detailed_description />
	<mesh_term>Neutropenia</mesh_term>
	<mesh_term>Mycoses</mesh_term>
	<mesh_term>Caspofungin</mesh_term>
	<mesh_term>Echinocandins</mesh_term>
	<criteria>Patient has had an absolute neutrophil count &lt; 500/mm3 for at least 96 hours (the patient must not be expected to recover from neutropenia in the next 48 hours), and has received at least 96 hours of parenteral broad spectrum systemic antibacterial therapy preceding study entry, and patient has fever &gt;38.0 Degrees Centigrade within the last 24 hours prior to study entry Appropriate antibiotics are those that provide broad spectrum grampositive and gramnegative coverage Patient has an inadequately managed bacterial infection at the time of enrollment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2015</verification_date>
</DOC>